Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers.

Saved in:
Bibliographic Details
Title: Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers.
Authors: Hellmann MD; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY. Electronic address: hellmanm@mskcc.org., Sturm I; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Berlin, Germany., Trnkova ZJ; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Berlin, Germany., Lettieri J; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Whippany, NJ., Diefenbach K; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Berlin, Germany., Rizvi NA; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY., Gettinger SN; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, Yale Cancer Center, New Haven, CT.
Source: Clinical lung cancer [Clin Lung Cancer] 2015 Nov; Vol. 16 (6), pp. 514-22. Date of Electronic Publication: 2015 Apr 20.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0690
DOI:10.1016/j.cllc.2015.04.003